Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study by Kelly Catherine M, Juurlink David N, Gomes Tara, Duong-Hua Minh, Pritchard Kathleen I, Austin Peter C, Paszat Lawrence F in BMJ (Clinical research ed.) (2010). PubMed

Abstract

To characterise whether some selective serotonin reuptake inhibitor (SSRI) antidepressants reduce tamoxifen's effectiveness by inhibiting its bioactivation by cytochrome P450 2D6 (CYP2D6).

[ hide abstract ]

Discussed In Paper

Related In Paper

Variant Annotations

None.